Dietitian-Nutritionist vs. Day Hospital in the Metabolic Control of Patients With Type 2 Diabetes
NUTRI-DIAB
NUTRI-DIAB: Impact of the Dietitian-Nutritionist Model vs. Day Hospital on the Metabolic Control of Patients With Type 2 Diabetes
1 other identifier
observational
140
1 country
1
Brief Summary
The present study aims to compare the effects on glycated hemoglobin (HbA1c) at 3 months of two care models in patients with type 2 diabetes referred due to poor glycemic control: a day hospital endocrinology care model versus a care model centered on follow-up by a dietitian-nutritionist.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2025
CompletedFirst Submitted
Initial submission to the registry
December 3, 2025
CompletedFirst Posted
Study publicly available on registry
December 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedDecember 16, 2025
December 1, 2025
10 months
December 3, 2025
December 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glycate hemoglobin
Glycated hemoglobin (HbA1c) levels three months after completion of the intervention
three months after completion of the intervention
Study Arms (2)
Day Care Hospital
These patients received joint care from a nurse and an endocrinologist in the day hospital before 2024.
Nutritionist
These patients received joint care from a nutriotinist and finally an endocrinologist in ambulatory care unit after 2024.
Interventions
Clinical follow-up under the joint care of a nurse and an endocrinologist at Day Care Hospital
Clinical follow-up with a dietitian-nutritionist and an endocrinologist at ambulatory care unit
Eligibility Criteria
Patients affected by diabetes mellitus type 2
You may qualify if:
- Patients with a diagnosis of type 2 diabetes (T2DM) referred to endocrinology due to poor metabolic control.
- Patients on insulin therapy
You may not qualify if:
- Referred from primary care for other reasons such as hypoglycemia.
- Patients with other types of diabetes mellitus or with uncertainty in diagnostic classification.
- Patients on rapid-acting insulin bolus therapy.
- Patients with acute decompensation of diabetes.
- Patients receiving corticosteroid treatment.
- Dependent individuals for activities of daily living (ADL) with a Barthel index score below 60 or with cognitive impairment.
- Language barrier.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de Vilafranca
Vilafranca del Penedès, Barcelona, 08720, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 3, 2025
First Posted
December 16, 2025
Study Start
June 30, 2025
Primary Completion
April 30, 2026
Study Completion
April 30, 2026
Last Updated
December 16, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After publication of main results of the study.
- Access Criteria
- IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.
IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).